Last Updated on January 26, 2023
Strategic Plan 2022-2025;
Enhancing Access to Medicine for all by contributing to advancement in the health care regulations in Pakistan
Strategic Plan 2022-2025 sets ambitions for us to achieve our strategic objectives that contribute towards ensuring availability of quality assured, safe and effective Therapeutic Goods (TGs) in Pakistan. We are committed to maximize opportunities of treatment for patients for the people of Pakistan.
Here is the complete Strategic Plan 2022-2025
Goal 1: Optimized Regulatory System
-> Strengthening of Pharmacovigilance
-> Monitoring of Antimicrobial Consumption (AMC)
-> International Accreditations
-> Effective regulation of therapeutic goods
Goal 2: Better Informed Users
-> Safe and Rational use of therapeutic goods
-> Prompt communication with public
-> Improve public awareness
-> Involvement of all stakeholders
Goal 3: Access to Health Products by All
-> Addressing shortages
-> Early access to new treatments
-> Integrity of supply chain
-> MRPs regulation
Goal 4: Strengthening Internal Capabilities
-> Capacity building
-> Automation of Quality Management System (QMS)
-> Financial self-sufficiency
-> Strengthening infrastructure
Regardless of your medical and healthcare needs, we are always at your service, because we are dedicated to giving you the highest quality care services.
Evidence based Decision Making
Our medical and healthcare services encompass general health conditions to specific problems. We ensure to give you the best-in-class care and service at every step.
Collaboration and Harmonization
Our doctors and staff are committed to providing top-notch medical services to all our patients. We have you covered for all your healthcare needs.
Regulatory Reliance
Our doctors and staff are committed to providing top-notch medical services to all our patients. We have you covered for all your healthcare needs.
“IIt is the first time that DRAP has outlined its strategic plan based on the necessary improvements that regulatory framework requires at this time. This document will allow us to move quickly towards establishing an agile regulatory system to protect the citizens of Pakistan from spurious and sub-standard therapeutic goods”
Asim Rauf, CEO DRAP
